Breast cancer therapy (BriaCell Therapeutics)

N/A

Report date: 2024/11/12 15:24:15

Base Information

Drug NameBreast cancer therapy (BriaCell Therapeutics)
Drug Alias NamePersonalised cancer therapy (BriaCell Therapeutics)Bria-APTCBria-OTS 2.0Bria-OTS™Bria-OTS™
ClassificationCell and gene therapy > Cell therapy
Mechanisms of ActionMacrophage colony stimulating factor 2 modulators
TargetsMacrophage colony stimulating factor 2
Therapy Area/IndicationsMetastatic breast cancerBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesBriacell Therapeutics Corp
China Registration ClassN/A

Develop Information

Active CompaniesBriacell Therapeutics Corp
Inactive CompaniesN/A
Active IndicationsMetastatic breast cancerBreast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A